Knee Osteoarthritis (OA): Clinical Trials

4 trials for Knee Osteoarthritis (OA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 2, Active not recruiting 1, Completed 1
Phase 11Active not recruiting 1
Phase 31Completed 1

Follow Knee Osteoarthritis (OA): new trials by email Literature Review of Knee Osteoarthritis (OA) trials Research Report on Knee Osteoarthritis (OA)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis
Genicular Artery Embolization, Lipiodol, Simple angiogram - Knee Osteoarthritis, Knee Osteoarthritis (Knee OA)
Phase 2RecruitingUniversity of Utah402026-07-012026-10-30
Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)
Somatropin (recombinant human growth hormone), bacteriostatic saline placebo - Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA)
Phase 1 / Phase 2Active not recruitingDr. David Wasserstein342025-10-312026-07-31
The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis
Participants are given Ibuprofen 400 mg to take for 7 days on the day they receive a dextrose prolotherapy (DPT) injection. These procedures are repeated every 3-5 weeks for a total of 3 times., Participants are given a placebo to take for 7 days on the day they receive a dextrose prolotherapy (DPT) injection. These procedures are repeated every 3-5 weeks for a total of 3 times. - Knee Osteoarthritis (OA)
Phase 2RecruitingDavid Grant U.S. Air Force Medical Center682025-03-312025-11-24
A Placebo-Controlled Study of Collagen Hydrolysate in Subjects With Knee Osteoarthritis (OA)
Collagen Hydrolysate, Placebo - Knee Osteoarthritis (OA)
Phase 2 / Phase 3CompletedGELITA302007-03-012009-02-06

Narrower conditions

Osteoarthritis, Knee (4)  ·  Osteoarthritis (2)  ·  Musculoskeletal Pain (1)

Broader conditions

Arthritis (4)  ·  Joint Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Rheumatic Diseases (4)  ·  Osteoarthritis (2)  ·  Muscular Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Growth Hormone (1)  ·  Human Growth Hormone (1)

Sponsors

David Grant U.S. Air Force Medical Center (1)  ·  Dr. David Wasserstein (1)  ·  GELITA (1)  ·  University of Utah (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Alexander R Kim, MD (1)  ·  Dr. David Wasserstein (1)  ·  Osman Ahmed, MD (1)  ·  Timothy E McAlindon, MD, MPH (1)

Results publications

PMID 28808182, PMID 41638751

NIH funding

R21AR082123 (1)